Clinical Significance and Effect of lncRNA HOXA11-AS in NSCLC: A Study Based on Bioinformatics, In Vitro and in Vivo Verification

Abstract HOXA11 antisense RNA (HOXA11-AS) has been shown to be involved in tumorigenesis and development of different cancers. However, the role of HOXA11-AS in non-small cell lung cancer (NSCLC) remains unclear. In this study, we firstly explored and confirmed the expression of HOXA11-AS in NSCLC t...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Yu Zhang, Wen-jie Chen, Ting-qing Gan, Xiu-ling Zhang, Zu-cheng Xie, Zhi-hua Ye, Yun Deng, Ze-feng Wang, Kai-teng Cai, Shi-kang Li, Dian-zhong Luo, Gang Chen
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2017
Materias:
R
Q
Acceso en línea:https://doaj.org/article/a9a7e6dbe4514844bfc72a8d6a574a7e
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:a9a7e6dbe4514844bfc72a8d6a574a7e
record_format dspace
spelling oai:doaj.org-article:a9a7e6dbe4514844bfc72a8d6a574a7e2021-12-02T15:06:04ZClinical Significance and Effect of lncRNA HOXA11-AS in NSCLC: A Study Based on Bioinformatics, In Vitro and in Vivo Verification10.1038/s41598-017-05856-22045-2322https://doaj.org/article/a9a7e6dbe4514844bfc72a8d6a574a7e2017-07-01T00:00:00Zhttps://doi.org/10.1038/s41598-017-05856-2https://doaj.org/toc/2045-2322Abstract HOXA11 antisense RNA (HOXA11-AS) has been shown to be involved in tumorigenesis and development of different cancers. However, the role of HOXA11-AS in non-small cell lung cancer (NSCLC) remains unclear. In this study, we firstly explored and confirmed the expression of HOXA11-AS in NSCLC tissues and cells. Cytometry, CCK-8, cell scratch, migration, Matrigel invasion and flow cytometry assays were performed to determine the biological impact of HOXA11-AS in vitro. Furthermore, a chick embryo chorioallantoic membrane (CAM) model of NSCLC was constructed to explore the effect of HOXA11-AS on tumorigenicity and angiogenesis in vivo. Additionally, bioinformatics analyses were performed to investigate the prospective pathways of HOXA11-AS co-expressed genes. As results, HOXA11-AS was markedly highly expressed in NSCLC tissues and cells. Furthermore, the proliferation, migration, invasion, tumorigenic and angiogenic ability of NSCLC cells were all inhibited and apoptosis was induced after HOXA11-AS knock-down. HOXA11-AS RNAi also led to cell cycle arrest on G0/G1 or G2/M phase. In addition, the non-small cell lung cancer pathway might be involved in regulating the co-expressed genes of HOXA11-AS in NSCLC. These results indicate that HOXA11-AS plays pivotal roles in NSCLC and it can become a novel therapeutic direction for treating NSCLC.Yu ZhangWen-jie ChenTing-qing GanXiu-ling ZhangZu-cheng XieZhi-hua YeYun DengZe-feng WangKai-teng CaiShi-kang LiDian-zhong LuoGang ChenNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 7, Iss 1, Pp 1-18 (2017)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Yu Zhang
Wen-jie Chen
Ting-qing Gan
Xiu-ling Zhang
Zu-cheng Xie
Zhi-hua Ye
Yun Deng
Ze-feng Wang
Kai-teng Cai
Shi-kang Li
Dian-zhong Luo
Gang Chen
Clinical Significance and Effect of lncRNA HOXA11-AS in NSCLC: A Study Based on Bioinformatics, In Vitro and in Vivo Verification
description Abstract HOXA11 antisense RNA (HOXA11-AS) has been shown to be involved in tumorigenesis and development of different cancers. However, the role of HOXA11-AS in non-small cell lung cancer (NSCLC) remains unclear. In this study, we firstly explored and confirmed the expression of HOXA11-AS in NSCLC tissues and cells. Cytometry, CCK-8, cell scratch, migration, Matrigel invasion and flow cytometry assays were performed to determine the biological impact of HOXA11-AS in vitro. Furthermore, a chick embryo chorioallantoic membrane (CAM) model of NSCLC was constructed to explore the effect of HOXA11-AS on tumorigenicity and angiogenesis in vivo. Additionally, bioinformatics analyses were performed to investigate the prospective pathways of HOXA11-AS co-expressed genes. As results, HOXA11-AS was markedly highly expressed in NSCLC tissues and cells. Furthermore, the proliferation, migration, invasion, tumorigenic and angiogenic ability of NSCLC cells were all inhibited and apoptosis was induced after HOXA11-AS knock-down. HOXA11-AS RNAi also led to cell cycle arrest on G0/G1 or G2/M phase. In addition, the non-small cell lung cancer pathway might be involved in regulating the co-expressed genes of HOXA11-AS in NSCLC. These results indicate that HOXA11-AS plays pivotal roles in NSCLC and it can become a novel therapeutic direction for treating NSCLC.
format article
author Yu Zhang
Wen-jie Chen
Ting-qing Gan
Xiu-ling Zhang
Zu-cheng Xie
Zhi-hua Ye
Yun Deng
Ze-feng Wang
Kai-teng Cai
Shi-kang Li
Dian-zhong Luo
Gang Chen
author_facet Yu Zhang
Wen-jie Chen
Ting-qing Gan
Xiu-ling Zhang
Zu-cheng Xie
Zhi-hua Ye
Yun Deng
Ze-feng Wang
Kai-teng Cai
Shi-kang Li
Dian-zhong Luo
Gang Chen
author_sort Yu Zhang
title Clinical Significance and Effect of lncRNA HOXA11-AS in NSCLC: A Study Based on Bioinformatics, In Vitro and in Vivo Verification
title_short Clinical Significance and Effect of lncRNA HOXA11-AS in NSCLC: A Study Based on Bioinformatics, In Vitro and in Vivo Verification
title_full Clinical Significance and Effect of lncRNA HOXA11-AS in NSCLC: A Study Based on Bioinformatics, In Vitro and in Vivo Verification
title_fullStr Clinical Significance and Effect of lncRNA HOXA11-AS in NSCLC: A Study Based on Bioinformatics, In Vitro and in Vivo Verification
title_full_unstemmed Clinical Significance and Effect of lncRNA HOXA11-AS in NSCLC: A Study Based on Bioinformatics, In Vitro and in Vivo Verification
title_sort clinical significance and effect of lncrna hoxa11-as in nsclc: a study based on bioinformatics, in vitro and in vivo verification
publisher Nature Portfolio
publishDate 2017
url https://doaj.org/article/a9a7e6dbe4514844bfc72a8d6a574a7e
work_keys_str_mv AT yuzhang clinicalsignificanceandeffectoflncrnahoxa11asinnsclcastudybasedonbioinformaticsinvitroandinvivoverification
AT wenjiechen clinicalsignificanceandeffectoflncrnahoxa11asinnsclcastudybasedonbioinformaticsinvitroandinvivoverification
AT tingqinggan clinicalsignificanceandeffectoflncrnahoxa11asinnsclcastudybasedonbioinformaticsinvitroandinvivoverification
AT xiulingzhang clinicalsignificanceandeffectoflncrnahoxa11asinnsclcastudybasedonbioinformaticsinvitroandinvivoverification
AT zuchengxie clinicalsignificanceandeffectoflncrnahoxa11asinnsclcastudybasedonbioinformaticsinvitroandinvivoverification
AT zhihuaye clinicalsignificanceandeffectoflncrnahoxa11asinnsclcastudybasedonbioinformaticsinvitroandinvivoverification
AT yundeng clinicalsignificanceandeffectoflncrnahoxa11asinnsclcastudybasedonbioinformaticsinvitroandinvivoverification
AT zefengwang clinicalsignificanceandeffectoflncrnahoxa11asinnsclcastudybasedonbioinformaticsinvitroandinvivoverification
AT kaitengcai clinicalsignificanceandeffectoflncrnahoxa11asinnsclcastudybasedonbioinformaticsinvitroandinvivoverification
AT shikangli clinicalsignificanceandeffectoflncrnahoxa11asinnsclcastudybasedonbioinformaticsinvitroandinvivoverification
AT dianzhongluo clinicalsignificanceandeffectoflncrnahoxa11asinnsclcastudybasedonbioinformaticsinvitroandinvivoverification
AT gangchen clinicalsignificanceandeffectoflncrnahoxa11asinnsclcastudybasedonbioinformaticsinvitroandinvivoverification
_version_ 1718388602880131072